Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,258,644
-$3,917,005 QoQ
Shares Held
738,032
-28.2% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. JANX ranks #80 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | QNCX |
Quince Therapeutics, Inc.
|
5,200,000 | $105,040,000 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 |
All Filings in JANX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,258,644 | 738,032 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,175,649 | 1,027,221 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,098,364 | 1,026,938 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,688,767 | 1,241,938 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $39,341,565 | 1,457,095 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $99,166,091 | 1,852,187 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $72,699,948 | 1,600,263 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,601,559 | 300,825 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,123,777 | 29,848 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $863,936 | 85,708 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,629,751 | 137,300 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,661,330 | 137,300 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,655,643 | 505,364 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,418,450 | 400,181 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,496,736 | 286,383 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,991,151 | 278,323 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,490,365 | 278,275 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,489,670 | 300,031 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,339,787 | 334,260 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||